Table of Contents EMEA (Europe, Middle East and Africa) Celiac Disease Drug Market Report 2018 1 Celiac Disease Drug Overview 1.1 Product Overview and Scope of Celiac Disease Drug 1.2 Classification of Celiac Disease Drug 1.2.1 EMEA Celiac Disease Drug Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 EMEA Celiac Disease Drug Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Distension 1.2.4 Diarrhea 1.2.5 Anorexia 1.2.6 Others 1.3 EMEA Celiac Disease Drug Market by Application/End Users 1.3.1 EMEA Celiac Disease Drug Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 First line of treatment 1.3.3 Second line of treatment 1.4 EMEA Celiac Disease Drug Market by Region 1.4.1 EMEA Celiac Disease Drug Market Size (Value) Comparison by Region (2013-2025) 1.4.2 Europe Status and Prospect (2013-2025) 1.4.3 Middle East Status and Prospect (2013-2025) 1.4.4 Africa Status and Prospect (2013-2025) 1.5 EMEA Market Size (Value and Volume) of Celiac Disease Drug (2013-2025) 1.5.1 EMEA Celiac Disease Drug Sales and Growth Rate (2013-2025) 1.5.2 EMEA Celiac Disease Drug Revenue and Growth Rate (2013-2025) 2 EMEA Celiac Disease Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Celiac Disease Drug Market Competition by Players/Manufacturers 2.1.1 EMEA Celiac Disease Drug Sales Volume and Market Share of Major Players (2013-2018) 2.1.2 EMEA Celiac Disease Drug Revenue and Share by Players (2013-2018) 2.1.3 EMEA Celiac Disease Drug Sale Price by Players (2013-2018) 2.2 EMEA Celiac Disease Drug (Volume and Value) by Type/Product Category 2.2.1 EMEA Celiac Disease Drug Sales and Market Share by Type (2013-2018) 2.2.2 EMEA Celiac Disease Drug Revenue and Market Share by Type (2013-2018) 2.2.3 EMEA Celiac Disease Drug Sale Price by Type (2013-2018) 2.3 EMEA Celiac Disease Drug (Volume) by Application 2.4 EMEA Celiac Disease Drug (Volume and Value) by Region 2.4.1 EMEA Celiac Disease Drug Sales and Market Share by Region (2013-2018) 2.4.2 EMEA Celiac Disease Drug Revenue and Market Share by Region (2013-2018) 2.4.3 EMEA Celiac Disease Drug Sales Price by Region (2013-2018) 3 Europe Celiac Disease Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Celiac Disease Drug Sales and Value (2013-2018) 3.1.1 Europe Celiac Disease Drug Sales Volume and Growth Rate (2013-2018) 3.1.2 Europe Celiac Disease Drug Revenue and Growth Rate (2013-2018) 3.2 Europe Celiac Disease Drug Sales and Market Share by Type 3.3 Europe Celiac Disease Drug Sales and Market Share by Application 3.4 Europe Celiac Disease Drug Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Celiac Disease Drug Sales Volume by Countries (2013-2018) 3.4.2 Europe Celiac Disease Drug Revenue by Countries (2013-2018) 3.4.3 Germany Celiac Disease Drug Sales and Growth Rate (2013-2018) 3.4.4 France Celiac Disease Drug Sales and Growth Rate (2013-2018) 3.4.5 UK Celiac Disease Drug Sales and Growth Rate (2013-2018) 3.4.6 Russia Celiac Disease Drug Sales and Growth Rate (2013-2018) 3.4.7 Italy Celiac Disease Drug Sales and Growth Rate (2013-2018) 3.4.8 Benelux Celiac Disease Drug Sales and Growth Rate (2013-2018) 4 Middle East Celiac Disease Drug (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Celiac Disease Drug Sales and Value (2013-2018) 4.1.1 Middle East Celiac Disease Drug Sales Volume and Growth Rate (2013-2018) 4.1.2 Middle East Celiac Disease Drug Revenue and Growth Rate (2013-2018) 4.2 Middle East Celiac Disease Drug Sales and Market Share by Type 4.3 Middle East Celiac Disease Drug Sales and Market Share by Application 4.4 Middle East Celiac Disease Drug Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Celiac Disease Drug Sales Volume by Countries (2013-2018) 4.4.2 Middle East Celiac Disease Drug Revenue by Countries (2013-2018) 4.4.3 Saudi Arabia Celiac Disease Drug Sales and Growth Rate (2013-2018) 4.4.4 Israel Celiac Disease Drug Sales and Growth Rate (2013-2018) 4.4.5 UAE Celiac Disease Drug Sales and Growth Rate (2013-2018) 4.4.6 Iran Celiac Disease Drug Sales and Growth Rate (2013-2018) 5 Africa Celiac Disease Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Celiac Disease Drug Sales and Value (2013-2018) 5.1.1 Africa Celiac Disease Drug Sales Volume and Growth Rate (2013-2018) 5.1.2 Africa Celiac Disease Drug Revenue and Growth Rate (2013-2018) 5.2 Africa Celiac Disease Drug Sales and Market Share by Type 5.3 Africa Celiac Disease Drug Sales and Market Share by Application 5.4 Africa Celiac Disease Drug Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Celiac Disease Drug Sales Volume by Countries (2013-2018) 5.4.2 Africa Celiac Disease Drug Revenue by Countries (2013-2018) 5.4.3 South Africa Celiac Disease Drug Sales and Growth Rate (2013-2018) 5.4.4 Nigeria Celiac Disease Drug Sales and Growth Rate (2013-2018) 5.4.5 Egypt Celiac Disease Drug Sales and Growth Rate (2013-2018) 5.4.6 Algeria Celiac Disease Drug Sales and Growth Rate (2013-2018) 6 EMEA Celiac Disease Drug Manufacturers/Players Profiles and Sales Data 6.1 F. Hoffmann-La Roche 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Celiac Disease Drug Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Johnson & Johnson 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Celiac Disease Drug Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Johnson & Johnson Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Merck 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Celiac Disease Drug Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Merck Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Pfizer 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Celiac Disease Drug Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Pfizer Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 ADMA Biologics 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Celiac Disease Drug Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 ADMA Biologics Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 Amgen 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Celiac Disease Drug Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Amgen Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 Anthera Pharmaceuticals 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Celiac Disease Drug Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Anthera Pharmaceuticals Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Bayer 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Celiac Disease Drug Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Bayer Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Biogen 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Celiac Disease Drug Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Biogen Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 BioLineRx 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Celiac Disease Drug Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 BioLineRx Celiac Disease Drug Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Biotest 6.12 Bristol-Myers Squibb 6.13 Celgene 6.14 Takeda Pharmaceutical 6.15 Novartis 6.16 LFB Group 6.17 Kedrion Biopharma 7 Celiac Disease Drug Manufacturing Cost Analysis 7.1 Celiac Disease Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Celiac Disease Drug 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Celiac Disease Drug Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Celiac Disease Drug Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Celiac Disease Drug Market Forecast (2018-2025) 11.1 EMEA Celiac Disease Drug Sales, Revenue and Price Forecast (2018-2025) 11.1.1 EMEA Celiac Disease Drug Sales and Growth Rate Forecast (2018-2025) 11.1.2 EMEA Celiac Disease Drug Revenue and Growth Rate Forecast (2018-2025) 11.1.3 EMEA Celiac Disease Drug Price and Trend Forecast (2018-2025) 11.2 EMEA Celiac Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.3 Europe Celiac Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.4 Middle Eastt Celiac Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.5 Africa Celiac Disease Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025) 11.6 EMEA Celiac Disease Drug Sales Forecast by Type (2018-2025) 11.7 EMEA Celiac Disease Drug Sales Forecast by Application (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Celiac Disease Drug Figure EMEA Celiac Disease Drug Sales Volume (K Pcs) by Type (2013-2025) Figure EMEA Celiac Disease Drug Sales Volume Market Share by Type (Product Category) in 2017 Figure Distension Product Picture Figure Diarrhea Product Picture Figure Anorexia Product Picture Figure Others Product Picture Figure EMEA Celiac Disease Drug Sales Volume (K Pcs) by Application (2013-2025) Figure EMEA Sales Market Share of Celiac Disease Drug by Application in 2017 Figure First line of treatment Examples Table Key Downstream Customer in First line of treatment Figure Second line of treatment Examples Table Key Downstream Customer in Second line of treatment Figure EMEA Celiac Disease Drug Market Size (Million USD) by Region (2013-2025) Figure Europe Celiac Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Celiac Disease Drug Revenue (Million USD) Status and Forecast by Countries Figure Middle East Celiac Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Middle East Celiac Disease Drug Revenue (Million USD) Status and Forecast by Countries Figure Africa Celiac Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Africa Celiac Disease Drug Revenue (Million USD) Status and Forecast by Countries Figure EMEA Celiac Disease Drug Sales Volume and Growth Rate (2013-2025) Figure EMEA Celiac Disease Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure EMEA Celiac Disease Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018) Table EMEA Celiac Disease Drug Sales Volume (K Pcs) of Major Players (2013-2018) Table EMEA Celiac Disease Drug Sales Share by Players (2013-2018) Figure 2017 Celiac Disease Drug Sales Share by Players Figure 2017 Celiac Disease Drug Sales Share by Players Figure EMEA Celiac Disease Drug Market Major Players Product Revenue (Million USD) (2013-2018) Table EMEA Celiac Disease Drug Revenue (Million USD) by Players (2013-2018) Table EMEA Celiac Disease Drug Revenue Share by Players (2013-2018) Table 2017 EMEA Celiac Disease Drug Revenue Share by Players Table 2017 EMEA Celiac Disease Drug Revenue Share by Players Table EMEA Celiac Disease Drug Sale Price (USD/Pcs) by Players (2013-2018) Table EMEA Celiac Disease Drug Sales (K Pcs) and Market Share by Type (2013-2018) Table EMEA Celiac Disease Drug Sales Share by Type (2013-2018) Figure Sales Market Share of Celiac Disease Drug by Type (2013-2018) Figure EMEA Celiac Disease Drug Sales Market Share by Type (2013-2018) Table EMEA Celiac Disease Drug Revenue (Million USD) and Market Share by Type (2013-2018) Table EMEA Celiac Disease Drug Revenue Share by Type (2013-2018) Figure Revenue Market Share of Celiac Disease Drug by Type in 2017 Table EMEA Celiac Disease Drug Sale Price (USD/Pcs) by Type (2013-2018) Table EMEA Celiac Disease Drug Sales (K Pcs) and Market Share by Application (2013-2018) Table EMEA Celiac Disease Drug Sales Share by Application (2013-2018) Figure Sales Market Share of Celiac Disease Drug by Application (2013-2018) Figure EMEA Celiac Disease Drug Sales Market Share by Application in 2017 Table EMEA Celiac Disease Drug Sales (K Pcs) and Market Share by Region (2013-2018) Table EMEA Celiac Disease Drug Sales Share by Region (2013-2018) Figure Sales Market Share of Celiac Disease Drug by Region (2013-2018) Figure EMEA Celiac Disease Drug Sales Market Share in 2017 Table EMEA Celiac Disease Drug Revenue (Million USD) and Market Share by Region (2013-2018) Table EMEA Celiac Disease Drug Revenue Share by Region (2013-2018) Figure Revenue Market Share of Celiac Disease Drug by Region (2013-2018) Figure EMEA Celiac Disease Drug Revenue Market Share Regions in 2017 Table EMEA Celiac Disease Drug Sales Price (USD/Pcs) by Region (2013-2018) Figure Europe Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Europe Celiac Disease Drug Revenue and Growth Rate (2013-2018) Table Europe Celiac Disease Drug Sales (K Pcs) by Type (2013-2018) Table Europe Celiac Disease Drug Market Share by Type (2013-2018) Figure Europe Celiac Disease Drug Market Share by Type in 2017 Table Europe Celiac Disease Drug Sales (K Pcs) by Application (2013-2018) Table Europe Celiac Disease Drug Market Share by Application (2013-2018) Figure Europe Celiac Disease Drug Market Share by Application in 2017 Table Europe Celiac Disease Drug Sales (K Pcs) by Countries (2013-2018) Table Europe Celiac Disease Drug Sales Market Share by Countries (2013-2018) Figure Europe Celiac Disease Drug Sales Market Share by Countries (2013-2018) Figure Europe Celiac Disease Drug Sales Market Share by Countries in 2017 Table Europe Celiac Disease Drug Revenue (Million USD) by Countries (2013-2018) Table Europe Celiac Disease Drug Revenue Market Share by Countries (2013-2018) Figure Europe Celiac Disease Drug Revenue Market Share by Countries (2013-2018) Figure Europe Celiac Disease Drug Revenue Market Share by Countries in 2017 Figure Germany Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure France Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure UK Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Russia Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Italy Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Benelux Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Middle East Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Middle East Celiac Disease Drug Revenue (Million USD) and Growth Rate (2013-2018) Table Middle East Celiac Disease Drug Sales (K Pcs) by Type (2013-2018) Table Middle East Celiac Disease Drug Market Share by Type (2013-2018) Figure Middle East Celiac Disease Drug Market Share by Type (2013-2018) Table Middle East Celiac Disease Drug Sales (K Pcs) by Applications (2013-2018) Table Middle East Celiac Disease Drug Market Share by Applications (2013-2018) Figure Middle East Celiac Disease Drug Sales Market Share by Application in 2017 Table Middle East Celiac Disease Drug Sales Volume (K Pcs) by Countries (2013-2018) Table Middle East Celiac Disease Drug Sales Volume Market Share by Countries (2013-2018) Figure Middle East Celiac Disease Drug Sales Volume Market Share by Countries in 2017 Table Middle East Celiac Disease Drug Revenue (Million USD) by Countries (2013-2018) Table Middle East Celiac Disease Drug Revenue Market Share by Countries (2013-2018) Figure Middle East Celiac Disease Drug Revenue Market Share by Countries (2013-2018) Figure Middle East Celiac Disease Drug Revenue Market Share by Countries in 2017 Figure Saudi Arabia Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Israel Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure UAE Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Iran Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Africa Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Africa Celiac Disease Drug Revenue (Million USD) and Growth Rate (2013-2018) Table Africa Celiac Disease Drug Sales (K Pcs) by Type (2013-2018) Table Africa Celiac Disease Drug Sales Market Share by Type (2013-2018) Figure Africa Celiac Disease Drug Sales Market Share by Type (2013-2018) Figure Africa Celiac Disease Drug Sales Market Share by Type in 2017 Table Africa Celiac Disease Drug Sales (K Pcs) by Application (2013-2018) Table Africa Celiac Disease Drug Sales Market Share by Application (2013-2018) Figure Africa Celiac Disease Drug Sales Market Share by Application (2013-2018) Table Africa Celiac Disease Drug Sales Volume (K Pcs) by Countries (2013-2018) Table Africa Celiac Disease Drug Sales Market Share by Countries (2013-2018) Figure Africa Celiac Disease Drug Sales Market Share by Countries (2013-2018) Figure Africa Celiac Disease Drug Sales Market Share by Countries in 2017 Table Africa Celiac Disease Drug Revenue (Million USD) by Countries (2013-2018) Table Africa Celiac Disease Drug Revenue Market Share by Countries (2013-2018) Figure Africa Celiac Disease Drug Revenue Market Share by Countries (2013-2018) Figure Africa Celiac Disease Drug Revenue Market Share by Countries in 2017 Figure South Africa Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Nigeria Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Egypt Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Algeria Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Table F. Hoffmann-La Roche Celiac Disease Drug Basic Information List Table F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure F. Hoffmann-La Roche Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure F. Hoffmann-La Roche Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Johnson & Johnson Celiac Disease Drug Basic Information List Table Johnson & Johnson Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Johnson & Johnson Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Johnson & Johnson Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure Johnson & Johnson Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Merck Celiac Disease Drug Basic Information List Table Merck Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Merck Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Merck Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure Merck Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Pfizer Celiac Disease Drug Basic Information List Table Pfizer Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Pfizer Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Pfizer Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure Pfizer Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table ADMA Biologics Celiac Disease Drug Basic Information List Table ADMA Biologics Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure ADMA Biologics Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure ADMA Biologics Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure ADMA Biologics Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Amgen Celiac Disease Drug Basic Information List Table Amgen Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Amgen Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Amgen Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure Amgen Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Anthera Pharmaceuticals Celiac Disease Drug Basic Information List Table Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Anthera Pharmaceuticals Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure Anthera Pharmaceuticals Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Bayer Celiac Disease Drug Basic Information List Table Bayer Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Bayer Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Bayer Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure Bayer Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Biogen Celiac Disease Drug Basic Information List Table Biogen Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Biogen Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Biogen Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure Biogen Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table BioLineRx Celiac Disease Drug Basic Information List Table BioLineRx Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure BioLineRx Celiac Disease Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure BioLineRx Celiac Disease Drug Sales Market Share in EMEA (2013-2018) Figure BioLineRx Celiac Disease Drug Revenue Market Share in EMEA (2013-2018) Table Biotest Celiac Disease Drug Basic Information List Table Bristol-Myers Squibb Celiac Disease Drug Basic Information List Table Celgene Celiac Disease Drug Basic Information List Table Takeda Pharmaceutical Celiac Disease Drug Basic Information List Table Novartis Celiac Disease Drug Basic Information List Table LFB Group Celiac Disease Drug Basic Information List Table Kedrion Biopharma Celiac Disease Drug Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Celiac Disease Drug Figure Manufacturing Process Analysis of Celiac Disease Drug Figure Celiac Disease Drug Industrial Chain Analysis Table Raw Materials Sources of Celiac Disease Drug Major Manufacturers in 2017 Table Major Buyers of Celiac Disease Drug Table Distributors/Traders List Figure EMEA Celiac Disease Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025) Figure EMEA Celiac Disease Drug Revenue and Growth Rate Forecast (2018-2025) Figure EMEA Celiac Disease Drug Price (USD/Pcs) and Trend Forecast (2018-2025) Table EMEA Celiac Disease Drug Sales (K Pcs) Forecast by Region (2018-2025) Figure EMEA Celiac Disease Drug Sales Market Share Forecast by Region (2018-2025) Table EMEA Celiac Disease Drug Revenue (Million USD) Forecast by Region (2018-2025) Figure EMEA Celiac Disease Drug Revenue Market Share Forecast by Region (2018-2025) Table Europe Celiac Disease Drug Sales (K Pcs) Forecast by Countries (2018-2025) Figure Europe Celiac Disease Drug Sales Market Share Forecast by Countries (2018-2025) Table Europe Celiac Disease Drug Revenue (Million USD) Forecast by Countries (2018-2025) Figure Europe Celiac Disease Drug Revenue Market Share Forecast by Countries (2018-2025) Table Middle East Celiac Disease Drug Sales (K Pcs) Forecast by Countries (2018-2025) Figure Middle East Celiac Disease Drug Sales Market Share Forecast by Countries (2018-2025) Table Middle East Celiac Disease Drug Revenue (Million USD) Forecast by Countries (2018-2025) Figure Middle East Celiac Disease Drug Revenue Market Share Forecast by Countries (2018-2025) Table Africa Celiac Disease Drug Sales (K Pcs) Forecast by Countries (2018-2025) Figure Africa Celiac Disease Drug Sales Market Share Forecast by Countries (2018-2025) Table Africa Celiac Disease Drug Revenue (Million USD) Forecast by Countries (2018-2025) Figure Africa Celiac Disease Drug Revenue Market Share Forecast by Countries (2018-2025) Table EMEA Celiac Disease Drug Sales (K Pcs) Forecast by Type (2018-2025) Figure EMEA Celiac Disease Drug Sales Market Share Forecast by Type (2018-2025) Table EMEA Celiac Disease Drug Sales (K Pcs) Forecast by Application (2018-2025) Figure EMEA Celiac Disease Drug Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources